Tag

Tag: Inflammatory Disease

chemocentryx vifor fresenius medical care renal pharma anca vasculitis

26/11/2019 2 mins

Rare Inflammatory Disease Drug Beats Immunosuppressants in Phase III

21/10/2019 2 mins

Update: Abivax’s Ulcerative Colitis Drug Effective Long-Term

Adrenomed adrecizumab septic shock

12/09/2019 2 mins

French Biotech to Develop Septic Shock Therapy with €39M Series B

index pharmaceuticals ulcerative colitis inflammatory bowel disease

27/08/2019 1 min

Swedish Ulcerative Colitis Treatment Makes Phase II Comeback

acute respiratory distress syndrome pantherna berlin inflammatory disease

02/08/2019 3 mins

This Biotech Uses Messenger RNA to Treat Lethal Lung Inflammation

atlantic healthcare pouchitis inflammatory bowel disease

01/08/2019 2 mins

Atlantic Healthcare’s Inflammatory Bowel Disease RNA Drug Fails Phase III

inflammatory bowel disease treatment personalized medicine predictimmune

31/07/2019 2 mins

British Biotech Raises €11M to Market Personalized Medicine Test

popcorn lung breath therapeutics zambon

25/07/2019 1 min

German Biotech Breath Therapeutics Acquired in Deal Worth up to €500M

chemocentryx vifor fresenius medical care renal pharma anca vasculitis

04/07/2019 1 min

Dutch Antibodies for Autoimmune Diseases Boosted by €15M Series A

inflarx trial inflammatory disease fail skin

06/06/2019 2 mins

Shares Drop 90% as Antibody for Inflammatory Skin Disease Fails Phase II

microbiome fecal transplant maat pharma enterobiotix

22/05/2019 2 mins

Microbiome Companies Unite to Push for EU Regulation Reform

lausanne top _cover

08/05/2019 7 mins

Top 10 Biotechs in Lausanne

We use cookies to give you the best experience. If you click on accept, we also use tracking cookies for analytics and advertising purposes. Check our privacy policy for more details. By accepting, you support our independent media and its’ freely accessible content. You may withdraw your consent at any time.